Literature DB >> 24273350

Synthesis of piperlogs and analysis of their effects on cells.

Zarko V Boskovic1, Mahmud M Hussain, Drew J Adams, Mingji Dai, Stuart L Schreiber.   

Abstract

Piperlongumine (PL) is a naturally occurring small molecule previously shown to induce cell death preferentially in cancer cells relative to non-cancer cells. An initial effort to synthesize analogs highlighted the reactivities of both of piperlongumine's α,β-unsaturated imide functionalities as key features determining PL's cellular effects. In this study, a second-generation of analogs was synthesized and evaluated in cells to gain further insight into how the reactivity, number, and orientation of PL's reactive olefins contribute to its ability to alter the physiology of cells.

Entities:  

Keywords:  Michael acceptors; piperlongumine; reactive oxygen species; toxicity

Year:  2013        PMID: 24273350      PMCID: PMC3834962          DOI: 10.1016/j.tet.2013.05.080

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


  23 in total

Review 1.  Covalent modifiers: an orthogonal approach to drug design.

Authors:  Michele H Potashman; Mark E Duggan
Journal:  J Med Chem       Date:  2009-03-12       Impact factor: 7.446

Review 2.  Ruthenium-based heterocyclic carbene-coordinated olefin metathesis catalysts.

Authors:  Georgios C Vougioukalakis; Robert H Grubbs
Journal:  Chem Rev       Date:  2010-03-10       Impact factor: 60.622

Review 3.  The resurgence of covalent drugs.

Authors:  Juswinder Singh; Russell C Petter; Thomas A Baillie; Adrian Whitty
Journal:  Nat Rev Drug Discov       Date:  2011-04       Impact factor: 84.694

4.  Highly enantioselective, catalytic conjugate addition of cyanide to alpha,beta-unsaturated imides.

Authors:  Glenn M Sammis; Eric N Jacobsen
Journal:  J Am Chem Soc       Date:  2003-04-16       Impact factor: 15.419

Review 5.  Overview of the therapeutic potential of piplartine (piperlongumine).

Authors:  Daniel P Bezerra; Claudia Pessoa; Manoel O de Moraes; Nicolau Saker-Neto; Edilberto R Silveira; Leticia V Costa-Lotufo
Journal:  Eur J Pharm Sci       Date:  2012-12-11       Impact factor: 4.384

6.  Identification of a geldanamycin dimer that induces the selective degradation of HER-family tyrosine kinases.

Authors:  F F Zheng; S D Kuduk; G Chiosis; P N Münster; L Sepp-Lorenzino; S J Danishefsky; N Rosen
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

7.  Glutathione is an essential metabolite required for resistance to oxidative stress in the yeast Saccharomyces cerevisiae.

Authors:  C M Grant; F H MacIver; I W Dawes
Journal:  Curr Genet       Date:  1996-05       Impact factor: 3.886

Review 8.  Redox-directed cancer therapeutics: molecular mechanisms and opportunities.

Authors:  Georg T Wondrak
Journal:  Antioxid Redox Signal       Date:  2009-12       Impact factor: 8.401

9.  Piplartine induces genotoxicity in eukaryotic but not in prokaryotic model systems.

Authors:  Daniel P Bezerra; Marne C Vasconcellos; Miriana S Machado; Izabel V Villela; Renato M Rosa; Dinara J Moura; Cláudia Pessoa; Manoel O Moraes; Edilberto R Silveira; Mary Anne S Lima; Nayara C Aquino; João Antonio P Henriques; Jenifer Saffi; Letícia V Costa-Lotufo
Journal:  Mutat Res       Date:  2009-04-18       Impact factor: 2.433

10.  Nature and role of xenobiotic metabolizing esterases in rat liver, lung, skin and blood.

Authors:  N W McCracken; P G Blain; F M Williams
Journal:  Biochem Pharmacol       Date:  1993-01-07       Impact factor: 5.858

View more
  4 in total

1.  Structural and Biochemical Analyses Reveal the Mechanism of Glutathione S-Transferase Pi 1 Inhibition by the Anti-cancer Compound Piperlongumine.

Authors:  Wayne Harshbarger; Sudershan Gondi; Scott B Ficarro; John Hunter; Durga Udayakumar; Deepak Gurbani; William D Singer; Yan Liu; Lianbo Li; Jarrod A Marto; Kenneth D Westover
Journal:  J Biol Chem       Date:  2016-11-21       Impact factor: 5.157

2.  Senolytic activity of piperlongumine analogues: Synthesis and biological evaluation.

Authors:  Xingui Liu; Yingying Wang; Xuan Zhang; Zhengya Gao; Suping Zhang; Peizhong Shi; Xin Zhang; Lin Song; Howard Hendrickson; Daohong Zhou; Guangrong Zheng
Journal:  Bioorg Med Chem       Date:  2018-06-18       Impact factor: 3.641

3.  Discovery of piperlongumine as a potential novel lead for the development of senolytic agents.

Authors:  Yingying Wang; Jianhui Chang; Xingui Liu; Xuan Zhang; Suping Zhang; Xin Zhang; Daohong Zhou; Guangrong Zheng
Journal:  Aging (Albany NY)       Date:  2016-11-19       Impact factor: 5.682

4.  Synthetic lethality by targeting the RUVBL1/2-TTT complex in mTORC1-hyperactive cancer cells.

Authors:  Seung Ho Shin; Ji Su Lee; Jia-Min Zhang; Sungbin Choi; Zarko V Boskovic; Ran Zhao; Mengqiu Song; Rui Wang; Jie Tian; Mee-Hyun Lee; Jae Hwan Kim; Minju Jeong; Jung Hyun Lee; Michael Petukhov; Sam W Lee; Sang Gyun Kim; Lee Zou; Sanguine Byun
Journal:  Sci Adv       Date:  2020-07-31       Impact factor: 14.136

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.